Michael Bani
LightNews LightNews
banner
michaelbani.bsky.social
Michael Bani
@michaelbani.bsky.social
26 followers 24 following 53 posts
Director at Pharma Now | Co-Founder & CTO at Omnicon Instruments | 50YP @ ICCCS | Techie Pursuing Innovation
Posts Replies Media Videos
michaelbani.bsky.social
Big news! The FDA has accepted the review of AVT05, a biosimilar to Simponi. A step closer to affordable and effective treatments for inflammatory diseases! 🌟💉 #biosimilars #healthcareinnovation

www.pharmanow.live/latest-news/...
Alvotech And Teva Advance AVT05 - Pharma Now
The FDA accepts Alvotech and Teva’s AVT05 biosimilar for review, marking a key step in advancing treatment for inflammatory conditions.
www.pharmanow.live
January 28, 2025 at 11:40 PM
michaelbani.bsky.social
Flagship Pioneering partners with Cambridge institutions to accelerate life sciences innovation! This collaboration brings together cutting-edge research, talent development, and resource sharing to revolutionize healthcare.
www.pharmanow.live/latest-news/...
Flagship Pioneering Partners with Cambridge Institutions - Pharma Now
Flagship Pioneering teams up with CUHP and MTI to drive breakthroughs in research, innovation, and biotechnology.
www.pharmanow.live
January 24, 2025 at 10:42 PM
michaelbani.bsky.social
Veeva Systems and Zifo Technology are revolutionizing biopharma quality control with their new partnership! By integrating Veeva's LIMS with Zifo's qcKen platform, they're streamlining operations, accelerating data transfer, and improving GMP compliance.
www.pharmanow.live/latest-news/...
Veeva And Zifo Partner To Modernize Biopharma QC - Pharma Now
Pharma Now is the #1 Digital Magazine for Pharma & Pharma Tech Industry. Subscribe to the magazine today.
www.pharmanow.live
January 24, 2025 at 10:40 PM
michaelbani.bsky.social
Russia’s mRNA cancer vaccine is coming in 2025! It fights tumors and reduces metastasis. Could this be the future of cancer treatment? Stay tuned! #CancerVaccine #CancerResearch #MedicalBreakthrough #Cancer #Tumor #Oncology #mRNA #CancerTreatment #HealthNews #ScienceBreakthrough #AI
December 18, 2024 at 9:14 PM
michaelbani.bsky.social
Regeneron’s EYLEA HD just hit a milestone in treating retinal vein occlusion! Fewer injections, same vision gains. Is this the future of eye care? #EyleaHD #EyeHealth #VisionCare #MedicalBreakthrough #RetinalVeinOcclusion #EyeCare #Vision #HealthNews #ClinicalTrials #MedicalInnovation #ForYou #FYP
December 18, 2024 at 9:13 PM
michaelbani.bsky.social
First-ever UKidney transplant completed! United Therapeutics is solving organ shortages with genetically engineered pig kidneys. A life-changing breakthrough! #OrganTransplant #UKidney
#MedicalNews #HealthBreakthrough #OrganDonation #KidneyTransplant #Xenotransplantation #GeneticEngineering
December 18, 2024 at 8:46 PM
michaelbani.bsky.social
BIG news for lung cancer patients in China! Merck’s KEYTRUDA is now approved for earlier stages of NSCLC, showing incredible results in survival and recurrence reduction. #CancerNews #Immunotherapy #Cancer #LungCancer #CancerResearch #Tumor #CancerTreatment #Healthcare #Immunotherapy
December 17, 2024 at 9:35 PM
michaelbani.bsky.social
Reviva’s Brilaroxazine shows long-term symptom relief in schizophrenia patients! Positive Phase 3 results bring hope to millions. Follow for more updates on breakthroughs! #Schizophrenia #MentalHealthAwareness #ClinicalTrials #Schizophrenia #MentalHealth #PharmaNews #Healthcare #MentalHealthMatters
December 17, 2024 at 9:33 PM
michaelbani.bsky.social
Foghorn Therapeutics pauses FHD-286 development but invests in innovative new cancer treatments, including partnerships with Lilly. Exciting progress ahead! Follow for more biotech news! #CancerResearch #Oncology #BiotechNews #Cancer #Biotech #Leukemia #ClinicalTrials #Healthcare #PharmaNews
December 17, 2024 at 9:31 PM
michaelbani.bsky.social
GSK’s Jemperli is changing the game for rectal cancer treatment! A 100% response rate without chemo or surgery—this is huge. Follow for more updates! #CancerTreatment #MedicalBreakthrough #FDAApproval #Cancer #CancerResearch #RectalCancer #Tumor #Oncology #Jemperli #FDA #HealthNews #PharmaNews
December 16, 2024 at 11:18 PM
michaelbani.bsky.social
Exciting news! Celltrion's biosimilars could soon treat retinal disorders, arthritis, and more across Europe. Affordable healthcare for all! #Biosimilar #AffordableHealthcare #ForYou #HealthNews #MedicalBreakthrough #Biosimilars #ForYouPage #FYP #HealthcareInnovation #Medicine #HealthUpdates #ForYou
December 16, 2024 at 11:14 PM
michaelbani.bsky.social
Novo Nordisk acquires three Catalent sites to expand production capacity. Short-term dips, but big long-term benefits!
#pharmaupdates #PharmaNews #HealthNews #NovoNordisk #HealthcareInnovation #Biotech #Catalent #ForYouPage #FYP #Medicine #ForYou
December 16, 2024 at 11:04 PM
michaelbani.bsky.social
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #GlobalHealth #RSV #HIV #Epilepsy
December 14, 2024 at 2:12 AM
michaelbani.bsky.social
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #PharmaceuticalIndustry #RSV #HIV
December 14, 2024 at 2:07 AM
michaelbani.bsky.social
Neffy is a needle-free epinephrine spray for severe allergies, now seeking approval in China, Japan, and Australia. A life-changing innovation! #AllergyRelief #HealthBreakthrough #MedicalNews #PharmaUpdates #Neffy #LifeChanging #Allergies #Innovation #AllergyRelief #SevereAllergies #HealthNews
December 14, 2024 at 2:04 AM
michaelbani.bsky.social
IBRANCE® boosts survival by 15+ months for HR+/HER2+ metastatic breast cancer patients in a new study. A huge step forward! #BreastCancer #CancerResearch #IBRANCE #Pfizer #HealthNews #Breakthrough #OncologyUpdates #BreastCancer #Cancer #Tumor #CancerResearch #HealthBreakthrough #MedicalNews #Pfizer
December 14, 2024 at 2:03 AM
michaelbani.bsky.social
Big news for adults with growth hormone deficiency! SKYTROFA® may soon expand to help more people live healthier lives. Stay tuned for updates! #MedicalBreakthrough #HealthNews #FDAUpdate #GrowthHormoneDeficiency#HealthNews #GrowthHormone #MedicalInnovation #FDAApproval #FYP #MedicalBreakthrough
December 14, 2024 at 2:00 AM
michaelbani.bsky.social
Lynparza just showed long-term survival benefits for breast cancer patients after 6 years of follow-up. A huge step forward in treatment!
#breastcancer #CancerResearch #CancerTreatment #Lynparza #BRCA #HER2Negative #HopeForCancer #MedicalInnovation #PharmaNews #CancerAwareness #BreastCancer
December 13, 2024 at 1:31 AM
michaelbani.bsky.social
Baxter just launched 5 new injectable products to fight infections, cancer, GERD, and seizures! Ready-to-use for better patient care. #healthcareinnovation #Pharma #Injectables #Cancer #Seizures #GERD #Antibacterial #MedicalInnovation #Healthcare #Pharma #Injectables #CancerTreatment
December 13, 2024 at 1:28 AM
michaelbani.bsky.social
AbbVie has acquired Aliada to accelerate the fight against Alzheimer’s with a new drug that targets the brain directly!
#neuroscience #healthcare #medicalnews #Alzheimers #AlzheimerTreatment #Neuroscience #PharmaNews #Healthcare #MedicalResearch #NewDrug #DrugDevelopment #BrainHealth #BigPharma
December 13, 2024 at 1:24 AM
michaelbani.bsky.social
Astria Therapeutics' STAR-0310 could transform treatment for atopic dermatitis with its long-lasting effects. Find out more about this exciting new therapy!
#EczemaRelief #AtopicDermatitis #HealthNews #FDAApproval #MedicalBreakthrough #SkinCareInnovation #ScienceNews #HealthBreakthroughs
December 11, 2024 at 9:23 PM
michaelbani.bsky.social
SPI-1005 offers hope for Meniere’s disease by improving hearing, speech, and balance. The future of hearing health is here!
#HearingHealth #TinnitusRelief #MeniereDisease #HearingLoss #MedicalInnovation #ClinicalTrials #BreakingNews #HealthBreakthrough #ScienceMatters #HealthUpdates #FollowForMore
December 11, 2024 at 9:21 PM
michaelbani.bsky.social
ZUPREME-1 is testing petrelintide, a weekly injection, for safe and effective weight management. A game-changer in the making!
#ObesityTreatment #WeightManagement #HealthBreakthrough #ZUPREME1 #Petrelintide #HealthNews #ClinicalTrials #ScienceMatters #MedicalInnovation #BreakingNews #HealthyLiving
December 11, 2024 at 9:19 PM
michaelbani.bsky.social
AbbVie’s Tavapadon shows huge potential for Parkinson’s patients in early stages. A hopeful step in treating this challenging condition.
#Parkinsons #BrainHealth #Neurology #ParkinsonsDisease #HealthNews #MedicalBreakthrough #ScienceUpdates #NewMedicines #ClinicalTrials #DiseaseAwareness
December 11, 2024 at 12:46 AM
michaelbani.bsky.social
CARVYKTI® is redefining treatment for multiple myeloma with higher MRD-negativity rates. Hope is here!
#MultipleMyeloma #CancerResearch #CancerBreakthrough #CAR-T #HealthNews #HopeForPatients #ChronicIllness #MedicalInnovation #FDAApproved #Hematology #CancerCare #ScienceUpdates #HealthMatters
December 11, 2024 at 12:44 AM